Thank you for stopping by. Below you will find more information about the charity and details on the projects the charity funds. You will also find our key spokespeople and our most recent stories and research news.
For all media enquiries, please contact firstname.lastname@example.org, or call +44 (0)300 777 7910.
For urgent out-of-hours media enquiries, please contact Debbi Jennings, Head of Brand Awareness, at DebbiJ@worldwidecancerresearch.org, or by calling +44 (0)7885 858 533.
Please note that these contact details are for media enquiries only. If you are looking to speak to our Supporter Services team please contact them at email@example.com or on +44 (0)300 777 7910. They’d be delighted to hear from you.
Worldwide Cancer Research is Scotland’s only cancer research charity which funds bold new research into any type of cancer. Each year, we back the brightest and best researchers in the UK and across the globe in their quests to find new ways to prevent, diagnose and treat cancer. The charity receives no government funding and we rely solely on the funds of our supporters to start cancer cures across the world.
Since Worldwide Cancer Research was founded in 1979, cancer survival rates have doubled but cancer remains the world’s second-biggest killer. In the last 40 years we have:
• Invested £200m into cancer research worldwide
• Devoted £100m to cancer research in the UK
• Funded 2000 projects in over 30 countries
• Funded 1200 researchers
Worldwide Cancer Research is currently funding 68 active projects. These are:
Rest of the UK:
Dr Helen Rippon became the Chief Executive of the charity after spending four years as the Head of Research. Before joining Worldwide Cancer Research, she held management positions at Prostate Cancer UK and Age UK.
Helen has over seventeen years’ experience in the field of cancer research. She also has a PhD in Molecular Biology from the University of York and was a Postdoctoral Research Fellow at Imperial College London.
David Sole played international rugby for Scotland from 1986 to 1992, where he then received an OBE for his services to the sport in 1993. Since then, David has worked with United Distillers and Diageo, Change Partnership and Whitehead Mann and most recently, co-founded the School for CEOs. David is also the writer of a regular column in daily and Sunday national papers.
Laura McLachlan is Director of Marketing and Fundraising at Worldwide Cancer Research, responsible for raising the charity’s profile and brand awareness, as well as a wide-ranging portfolio of fundraising and direct marketing including individual giving, legacies and events. Before joining Worldwide Cancer Research, Laura worked in education marketing and spent her early career in journalism and publishing. Laura has a law degree from the University of Glasgow and a masters in journalism studies from Strathclyde University.
Dr John Maher is a clinical immunologist and a cancer researcher at King’s College London. His research focuses on developing a new type of immunotherapy called CAR T-cell therapy. In 2015, Dr Maher and his team launched their first clinical trial as a result of their new discoveries in cancer immunotherapy. Dr Maher is also the current Chair of our Scientific Advisory Committee – the group of expert scientists that each year helps the charity pick the brightest and boldest research projects to fund.
Dr Lynn Turner is the Director of Research at Worldwide Cancer Research, responsible for the strategic development and operational oversight of the research-funding programme of the Charity. The Research Directorate is responsible for awarding funding, overseeing all active grants, communicating the science, and measuring the impact we are making as a cancer research charity. Lynn has a PhD in immunology from the University of Bath and postdoctoral research experience in a translational cancer research lab.